A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its.
Roivant Sciences' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm's.
Monitoring serum S100B levels may reduce exposure to cranial CT scans, thereby reducing their number, in children with mild head trauma when a clinical decision algorithm is followed.